Related Articles
A clinical study of cytokine-induced killer cells for the treatment of refractory lymphoma
Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a
Efficacy of cytokine‑induced killer cells targeting CD40 and GITR
Cytokine‑induced killer cell therapy for modulating regulatory T cells in patients with non‑small cell lung cancer
Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines